(NASDAQ: HYPR) Hyperfine's forecast annual revenue growth rate of 21.08% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.62%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.23%.
Hyperfine's revenue in 2024 is $11,032,000.On average, 2 Wall Street analysts forecast HYPR's revenue for 2024 to be $908,733,969, with the lowest HYPR revenue forecast at $899,380,413, and the highest HYPR revenue forecast at $918,087,525. On average, 1 Wall Street analysts forecast HYPR's revenue for 2025 to be $1,164,158,006, with the lowest HYPR revenue forecast at $1,164,158,006, and the highest HYPR revenue forecast at $1,164,158,006.
In 2026, HYPR is forecast to generate $1,418,143,034 in revenue, with the lowest revenue forecast at $1,418,143,034 and the highest revenue forecast at $1,418,143,034.